BMO Capital analyst Sean Dodge initiated coverage of HealthEquity (HQY) with a Market Perform rating and $100 price target The firm is positive on the backdrop for health savings account account growth but views the shares as fully valued heading into a lower rate environment.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- BMO Capital Maintains Hold Rating on HealthEquity Amid Strong EBITDA Growth and Valuation Concerns
- HealthEquity’s Strategic Initiatives and Market Opportunities Drive Buy Rating
- HealthEquity introduces GLP-1 telehealth, direct HSA enrollment platforms
- HealthEquity price target lowered to $120 from $125 at KeyBanc
- HealthEquity management to meet with KeyBanc